TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive? September 28, 2012
TCL Archive Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards February 7, 1997
TCL Archive FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications September 4, 2009